Kezar Life Sciences Inc
KZR
Market Cap$32.88M
Close$
$0.35
91.5% downside
Current Fair Value
91.5% downsideOvervalued by 91.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $32.88 Million |
|---|---|
| Enterprise Value | $7.31 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.15 |
| Beta | 0.61 |
| Outstanding Shares | 7,300,007 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.39 |
|---|---|
| PEG | 3.25 |
| Price to Sales | -4.12 |
| Price to Book Ratio | 0.26 |
| Enterprise Value to Revenue | -1.35 |
| Enterprise Value to EBIT | -0.08 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 2.21 |
| Debt to Equity | 0.14 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Kezar Life Sciences Inc
CEO: John Fowler